SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
BioPharm Executive: From the Bench to the Clinic
Alnylam’s victory with Patisiran in familial amyloid polyneuropathy (FAP) is significant for more than just the company and its patients.
October 14, 2017
 · 
1 min read
 · 
Karl Thiel
Drug Development
Johnson & Johnson’s New Xarelto Data Could Bring In $1.5 Billion In The U.S. Alone
August 28, 2017
 · 
1 min read
Why This Tiny Biotech is Giving Cash to Amgen Researchers
Drug Development
UCSF Heart Doctor Wary of Amgen-Paid Repatha Study
March 22, 2017
 · 
3 min read
Why This Tiny Biotech is Giving Cash to Amgen Researchers
Drug Development
Disappointment Hits as Amgen’s Repatha Prevents Heart Attacks, But Not Deaths
March 17, 2017
 · 
4 min read
Drug Development
Investors Anxiously Await for Amgen’s 27,500-Patient Heart Trial Data This Week
March 13, 2017
 · 
1 min read
Pharma Giant AstraZeneca PLC Scores Another FDA Breakthrough
Drug Development
AstraZeneca PLC Suffers Another Blow After Blood-Thinning Drug Flunks Trial
October 4, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Drug Development
Novo Nordisk A/S Investors Disappointed as Top Selling Drug Victoza Didn’t Do as Well as Expected
June 14, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Gilead Shuts Down Six Zydelig Trials Following European Medicines Agency Review
March 16, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Valeant Accused of Hiding Cold Drug Study Results Proving Drug Was No More Effective than a Placebo
February 2, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Regeneron Investors Get Jitters From False Praluent Data
January 7, 2016
 · 
2 min read
Load More
PRESS RELEASES
Drug Development
Mallinckrodt Will Conduct Phase IV Trial Of H.P. Acthar Gel (Repository Corticotropin Injection) For Symptomatic Sarcoidosis
October 9, 2017
 · 
9 min read
Drug Development
Amgen Release: First Randomized Study To Evaluate IMLYGIC (Talimogene Laherparepvec), An Oncolytic Viral Therapy, In Combination With A Checkpoint Inhibitor Published In The Journal Of Clinical Oncology
October 6, 2017
 · 
17 min read
Drug Development
Phase III Study Using 22nd Century Group, Inc.’s SPECTRUM Research Cigarettes Demonstrates Immediate Reduction To Very Low Nicotine Is Most Likely To Lead To Less Harm
October 6, 2017
 · 
5 min read
Drug Development
The Medicines Company To Present New Data From TANGO II Study Of VABOMERE (Meropenem And Vaborbactam) At IDWeek 2017
October 5, 2017
 · 
1 min read
Drug Development
Agena Biosciences Release: Highly Sensitive Assessment Of Common Somatic Mutations In Pulmonary Non-Small Cell Carcinoma With The MassARRAY System
September 27, 2017
 · 
3 min read
Drug Development
BioTime Announces Positive Secondary And Additional Positive Long-Term Data From The Renevia Pivotal Trial
September 26, 2017
 · 
6 min read
Drug Development
Novartis AG Release: New Analysis Shows Entresto Improved Physical And Social Activity In Patients With HFrEF
September 19, 2017
 · 
14 min read
Drug Development
Champions Oncology Announces Publication Highlighting Clinical Correlation Between Patient-Derived Xenograft (PDX) Model Responses And Patient Responses To Oncology Therapies
September 18, 2017
 · 
3 min read
Drug Development
Patients Switched To Alkermes’ ARISTADA Showed Significant Improvement In Schizophrenia Symptoms After Inadequate Response Or Intolerance To INVEGA SUSTENNA
September 18, 2017
 · 
13 min read
Drug Development
Novo Nordisk A/S Release: Tresiba Trial Shows That People With Type 2 Diabetes Who Avoid Severe Hypoglycemia Have A Reduced Risk Of Death
September 15, 2017
 · 
4 min read
Drug Development
Patient-Driven Dose Titration With Sanofi’s Toujeo Improved Blood Glucose Control Without Increasing Hypoglycemia Risk In Real-Life Clinical Practice
September 14, 2017
 · 
9 min read
Drug Development
LEO Pharma Announces More Than Half Of Patients On Kyntheum (Brodalumab) Maintain Consistent Levels Of Complete Skin Clearance For More Than Two Years
September 14, 2017
 · 
10 min read
Drug Development
Cannabis Science Announces Publication Of Initial Research Results Using Nanoparticle Drones To Target Lung Cancer With Radiosensitizers And Cannabinoids In The Renowned Journal Frontiers In Oncology
September 14, 2017
 · 
5 min read
Drug Development
Novo Nordisk A/S Release: Xultophy Reduces Cardiovascular Risk Factors In People With Type 2 Diabetes
September 13, 2017
 · 
4 min read
Drug Development
Fractyl And Collaborators Present One-Year Data On Revita DMR In Type 2 Diabetes At EASD 2017
September 13, 2017
 · 
4 min read
Drug Development
Bioventus Announces First Patients Enrolled In BONES Study For EXOGEN
September 13, 2017
 · 
3 min read
Drug Development
Daily Blood Glucose Measures In Phase III Clinical Trials Demonstrated Better Stability With Sanofi’s Toujeo Vs. Insulin Glargine 100 Units/mL
September 13, 2017
 · 
9 min read
Drug Development
First Patients Enrolled In UK’s Early Access To Medicines Scheme For Santheraa’s Raxone In Duchenne Muscular Dystrophy (DMD)
September 12, 2017
 · 
3 min read
Drug Development
Genomic Health Release: New Analysis From German Study Group Prospective Trial Shows Minimal Distant Recurrence In Patients With Clinically High-Risk Breast Cancer And Low Oncotype DX Breast Recurrence Score® Results Following Five Years Of Hormone Therap
September 12, 2017
 · 
8 min read
Drug Development
Sanofi’s Soliqua 100/33 Provided Earlier Blood Sugar Control Than Insulin Glargine 100 Units/mL
September 12, 2017
 · 
10 min read
Load More